Telomerase activity, apoptosis and cell cycle progression in ataxia telangiectasia lymphocytes expressing TCL1

C. Gabellini, A. Antonelli, P. Petrinelli, A. Biroccio, L. Marcucci, G. Nigro, G. Russo, G. Zupi, R. Elli

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Individuals affected by ataxia telangiectasia (AT) have a marked susceptibility to cancer. Ataxia telangiectasia cells, in addition to defects in cell cycle checkpoints, show dysfunction of apoptosis and of telomeres, which are both thought to have a role in the progression of malignancy. In 1-5% of patients with AT, clonal expansion of T lymphocytes carrying t(14;14) chromosomal translocation, deregulating TCL1 gene(s), has been described. While it is known that these cells can progress with time to a frank leukaemia, the molecular pathway leading to tumorigenesis has not yet been fully investigated. In this study, we compared AT clonal cells, representing 88% of the entire T lymphocytes (AT94-1) and expressing TCL1 oncogene (ATM- TCL1 +), cell cycle progression to T lymphocytes of AT patients without TCL1 expression (ATM- TCL1-) by analysing their spontaneous apoptosis rate, spontaneous telomerase activity and telomere instability. We show that in ATM- TCL1+ lymphocytes, apoptosis rate and cell cycle progression are restored back to a rate comparable with that observed in normal lymphocytes while telomere dysfunction is maintained.

Original languageEnglish
Pages (from-to)1091-1095
Number of pages5
JournalBritish Journal of Cancer
Volume89
Issue number6
DOIs
Publication statusPublished - Sep 15 2003

Fingerprint

Activity Cycles
Ataxia Telangiectasia
Telomerase
Cell Cycle
Lymphocytes
Apoptosis
Telomere
T-Lymphocytes
Genetic Translocation
Cell Cycle Checkpoints
Oncogenes
Neoplasms
Carcinogenesis
Leukemia
Genes

Keywords

  • Apoptosis
  • Ataxia telangiectasia
  • Cell cycle
  • TCL1
  • Telomere

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Telomerase activity, apoptosis and cell cycle progression in ataxia telangiectasia lymphocytes expressing TCL1. / Gabellini, C.; Antonelli, A.; Petrinelli, P.; Biroccio, A.; Marcucci, L.; Nigro, G.; Russo, G.; Zupi, G.; Elli, R.

In: British Journal of Cancer, Vol. 89, No. 6, 15.09.2003, p. 1091-1095.

Research output: Contribution to journalArticle

Gabellini, C. ; Antonelli, A. ; Petrinelli, P. ; Biroccio, A. ; Marcucci, L. ; Nigro, G. ; Russo, G. ; Zupi, G. ; Elli, R. / Telomerase activity, apoptosis and cell cycle progression in ataxia telangiectasia lymphocytes expressing TCL1. In: British Journal of Cancer. 2003 ; Vol. 89, No. 6. pp. 1091-1095.
@article{ad28e9a431ac446095207628b9ccb9fb,
title = "Telomerase activity, apoptosis and cell cycle progression in ataxia telangiectasia lymphocytes expressing TCL1",
abstract = "Individuals affected by ataxia telangiectasia (AT) have a marked susceptibility to cancer. Ataxia telangiectasia cells, in addition to defects in cell cycle checkpoints, show dysfunction of apoptosis and of telomeres, which are both thought to have a role in the progression of malignancy. In 1-5{\%} of patients with AT, clonal expansion of T lymphocytes carrying t(14;14) chromosomal translocation, deregulating TCL1 gene(s), has been described. While it is known that these cells can progress with time to a frank leukaemia, the molecular pathway leading to tumorigenesis has not yet been fully investigated. In this study, we compared AT clonal cells, representing 88{\%} of the entire T lymphocytes (AT94-1) and expressing TCL1 oncogene (ATM- TCL1 +), cell cycle progression to T lymphocytes of AT patients without TCL1 expression (ATM- TCL1-) by analysing their spontaneous apoptosis rate, spontaneous telomerase activity and telomere instability. We show that in ATM- TCL1+ lymphocytes, apoptosis rate and cell cycle progression are restored back to a rate comparable with that observed in normal lymphocytes while telomere dysfunction is maintained.",
keywords = "Apoptosis, Ataxia telangiectasia, Cell cycle, TCL1, Telomere",
author = "C. Gabellini and A. Antonelli and P. Petrinelli and A. Biroccio and L. Marcucci and G. Nigro and G. Russo and G. Zupi and R. Elli",
year = "2003",
month = "9",
day = "15",
doi = "10.1038/sj.bjc.6601213",
language = "English",
volume = "89",
pages = "1091--1095",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Telomerase activity, apoptosis and cell cycle progression in ataxia telangiectasia lymphocytes expressing TCL1

AU - Gabellini, C.

AU - Antonelli, A.

AU - Petrinelli, P.

AU - Biroccio, A.

AU - Marcucci, L.

AU - Nigro, G.

AU - Russo, G.

AU - Zupi, G.

AU - Elli, R.

PY - 2003/9/15

Y1 - 2003/9/15

N2 - Individuals affected by ataxia telangiectasia (AT) have a marked susceptibility to cancer. Ataxia telangiectasia cells, in addition to defects in cell cycle checkpoints, show dysfunction of apoptosis and of telomeres, which are both thought to have a role in the progression of malignancy. In 1-5% of patients with AT, clonal expansion of T lymphocytes carrying t(14;14) chromosomal translocation, deregulating TCL1 gene(s), has been described. While it is known that these cells can progress with time to a frank leukaemia, the molecular pathway leading to tumorigenesis has not yet been fully investigated. In this study, we compared AT clonal cells, representing 88% of the entire T lymphocytes (AT94-1) and expressing TCL1 oncogene (ATM- TCL1 +), cell cycle progression to T lymphocytes of AT patients without TCL1 expression (ATM- TCL1-) by analysing their spontaneous apoptosis rate, spontaneous telomerase activity and telomere instability. We show that in ATM- TCL1+ lymphocytes, apoptosis rate and cell cycle progression are restored back to a rate comparable with that observed in normal lymphocytes while telomere dysfunction is maintained.

AB - Individuals affected by ataxia telangiectasia (AT) have a marked susceptibility to cancer. Ataxia telangiectasia cells, in addition to defects in cell cycle checkpoints, show dysfunction of apoptosis and of telomeres, which are both thought to have a role in the progression of malignancy. In 1-5% of patients with AT, clonal expansion of T lymphocytes carrying t(14;14) chromosomal translocation, deregulating TCL1 gene(s), has been described. While it is known that these cells can progress with time to a frank leukaemia, the molecular pathway leading to tumorigenesis has not yet been fully investigated. In this study, we compared AT clonal cells, representing 88% of the entire T lymphocytes (AT94-1) and expressing TCL1 oncogene (ATM- TCL1 +), cell cycle progression to T lymphocytes of AT patients without TCL1 expression (ATM- TCL1-) by analysing their spontaneous apoptosis rate, spontaneous telomerase activity and telomere instability. We show that in ATM- TCL1+ lymphocytes, apoptosis rate and cell cycle progression are restored back to a rate comparable with that observed in normal lymphocytes while telomere dysfunction is maintained.

KW - Apoptosis

KW - Ataxia telangiectasia

KW - Cell cycle

KW - TCL1

KW - Telomere

UR - http://www.scopus.com/inward/record.url?scp=0141921837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141921837&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6601213

DO - 10.1038/sj.bjc.6601213

M3 - Article

C2 - 12966431

AN - SCOPUS:0141921837

VL - 89

SP - 1091

EP - 1095

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 6

ER -